INJECTION TECHNIQUE AND GLYCEMIC CONTROL (SB-103)

Thursday, October 26, 2023

13:40 – 14:00 EST

Location: Palais, 220CDE - Theatre 1

Presenter(s)

Lori Berard

Nurse Consultant
Independent
Akshay Jain, MD, FRCPC, FACE, CCD, ECNU, DABOM

Staff Endocrinologist
TLC Diabetes and Endocrinology
University of British Columbia

Disclosure(s):

Lori Berard: ABBOTT Diabetes Care: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Bayer: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Convatec: Consultant/Advisory Board (Ongoing); DexCOM: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Eli Lilly: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Embecta: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); HLS: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Novo Nordisk: Speaker/Honoraria (Ongoing); Sanofi: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Vertex: Consultant/Advisory Board (Ongoing)

Akshay Jain, MD, FRCPC, FACE, CCD, ECNU, DABOM: Abbott: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Amgen: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Astra Zeneca: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Bausch Healthcare: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Bayer: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Boehringer Ingelheim: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Dexcom: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Diabetes Canada: Speaker/Honoraria (Ongoing); Eli Lilly: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); HLS Therapeutics: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Insulet: Consultant/Advisory Board (Ongoing); Novo Nordisk: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); PocketPills: Consultant/Advisory Board (Ongoing); Timed Right: Speaker/Honoraria (Ongoing)

Sidebar Sessions are sponsored learning activities and are not part of the 2023 Vascular accredited program developed by the Scientific Planning Committee and do not qualify for Maintenance of Certification Section 1 credits.